跳至主要内容
临床试验/JPRN-UMIN000013794
JPRN-UMIN000013794已完成未知

Clinical Study of the GEM Combined Use Gamma Delta T Immune-Cells Treatment an Excision Impossible Paccreatic Cancer - Clinical Study of the GEM Combined Use Gamma Delta T Immune-Cells Treatment an Excision Impossible Paccreatic Cancer

Tomishiro Central Hospital0 个研究点目标入组 11 人开始时间: 2014年6月2日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
11

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) The patients with autoimmune disease 2) The patients with complications having poor control. (An infection, diabetes, hypertension, ischemic heart disease, cerebral infraction, etc.). 3) The patients egnancy nursing mother and the pregnant likelihood(possibility). 4) The patients history of the drug allergy. 5) The patients with double cancer. 6) The patients with HIV antibody-possitive. 7) The patients with locally advanced pancreatic cancer in need of radiotherapy . 8) Other, the patients is judged inadequate by research contact person

研究者

相似试验